Global Markets1 month ago
Pakistani Pharma Enters Global HIV Initiative
Ferozsons Laboratories Limited has joined Gilead Sciences’ expanded royalty-free licensing programme for investigational once-yearly lenacapavir for HIV prevention. The programme covers 120 high-incidence countries, primarily low-...